Analysis of Closed Claims in the Clinical Management of Rheumatoid Arthritis in Japan

机译：日本类风湿关节炎临床治疗中的无效要求分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background:Despite an increasing awareness of the risk of medical errors, few data sources are available to highlight the characteristics and patterns of medical errors in the clinical management of rheumatoid arthritis (RA). The present study aimed to evaluate medical malpractice claims associated with the management of RA and other autoimmune connective tissue diseases (ACTDs).

机译：背景：尽管人们对医疗错误风险的认识日益提高，但很少有数据来源能够突出类风湿关节炎（RA）临床管理中医疗错误的特征和模式。本研究旨在评估与RA和其他自身免疫性结缔组织病（ACTD）的治疗相关的医疗事故索赔。

著录项

期刊名称 Chinese Medical Journal
作者
Yasuhiro Otaki; Makiko DaSilva Ishida; Yuichi Saito; Yasuaki Oyama; Giichiro Oiso; Mitsuru Moriyama;
展开▼
作者单位

展开▼
年(卷),期 2017(130),12
年度 2017
页码 1454–1458
总页数 5
原文格式 PDF
正文语种
中图分类基础医学;
关键词
Autoimmune Connective Tissue Disease Closed Claim Rheumatoid Arthritis;

机译：自身免疫性结缔组织病;封闭性声明;类风湿关节炎;

相似文献

外文文献
中文文献
专利

1. Analysis of Closed Claims in the Clinical Management of Rheumatoid Arthritis in Japan [J] . Yasuhiro Otaki, Makiko DaSilva Ishida, Yuichi Saito, 中华医学杂志（英文版） . 2017,第012期

机译：日本类风湿关节炎临床治疗中的无效要求分析
2. Characteristics of claims in the management of septic arthritis in Japan: Retrospective analyses of judicial precedents and closed claims [J] . Yasuhiro Otaki, Makiko Ishida DaSilva, Yuichi Saito, Journal of the Chinese Medical Association: JCMA . 2018,第3期

机译：日本化脓性关节炎管理中的索赔特征：司法判例和封闭索赔的回顾性分析
3. Juries Trump FDA in Writing Drug Labels; FDA Grants Clinical Trial Permission for Human Embryonic Stem Cells; Alerts Issued for Two Biotechnology Products; Japanese Rheumatoid Arthritis Drug Approved in Europe; FDA Criticizes Humira Ad; Amgen's BLA for Bone Drug Accepted; Rules for Claiming Health Benefits from Food and Supplements [J] . Biotechnology Law Report . 2009,第2期

机译：陪审团特朗普FDA撰写药品标签； FDA授予人类胚胎干细胞临床试验许可；两种生物技术产品发出警报；日本在欧洲批准了类风湿关节炎药物； FDA批评Humira广告；接受了安进公司的骨药物BLA；从食品和补品中获取健康益处的规定
4. Immunogenic HLA-DR-presented-peptides Identified from Clinical Samples of Synovial Tissue/Fluid and Peripheral Blood from Patients with Rheumatoid Arthritis or Lyme Arthritis [C] . Qi Wang, Elise E. Drouin, Chunxiang Yao, ASMS Conference on Mass Spectrometry and Allied Topics . 2016

机译：免疫原性HLA-DR呈递肽，从类风湿性关节炎或莱姆关节炎患者的滑膜组织/液体和外周血的临床样本中鉴定出来
5. Selective cyclooxygenase-2 (COX-2) inhibition and risk of acute myocardial infarction or stroke in a population of rheumatoid arthritis and osteoarthritis patients from an administrative medical claims dataset. [D] . Spalding, William Michael. 2003

机译：来自行政医疗索赔数据集的类风湿关节炎和骨关节炎患者群体中的选择性环氧合酶2（COX-2）抑制和急性心肌梗塞或中风的风险。
6. Extended report: Effect of denosumab on Japanese patients with rheumatoid arthritis: a dose–response study of AMG 162 (Denosumab) in patients with RheumatoId arthritis on methotrexate to Validate inhibitory effect on bone Erosion (DRIVE)—a 12-month multicentre randomised double-blind placebo-controlled phase II clinical trial [O] . Tsutomu Takeuchi, Yoshiya Tanaka, Naoki Ishiguro, -1

机译：扩展报告：地诺单抗对日本类风湿关节炎患者的影响：风湿性关节炎甲氨蝶呤患者中AMG 162（Denosumab）的剂量反应研究以验证其对骨侵蚀（DRIVE）的抑制作用-一项为期12个月的多中心随机研究双盲安慰剂对照的II期临床试验
7. Analysis of Closed Claims in the Clinical Management of Rheumatoid Arthritis in Japan [O] . Yasuhiro Otaki, Makiko DaSilva Ishida, Yuichi Saito, 2017

机译：日本类风湿性关节炎临床管理中的封闭性主张分析

Analysis of Closed Claims in the Clinical Management of Rheumatoid Arthritis in Japan

摘要

著录项

相似文献

相关主题

期刊订阅